Credit: Adobe Stock
The passage of the One Big Beautiful Bill Act marked the largest health care funding cuts in modern history, and rural America is set to feel the deepest impact.
Medicaid reductions embedded in OBBBA are projected to strip more than $50 billion from rural hospital budgets over the next decade.
At the same time, an estimated 1.8 million rural residents could lose Medicaid coverage altogether.
For communities with fewer providers, limited facilities, and scarce pharmacy access, these changes threaten the very survival of rural care.
Even before the cuts, rural hospitals struggled.
Nearly half operated at a loss in 2023, and more than 330 are now considered at immediate risk of closing or cutting essential services.
When a hospital shuts down, the effects ripple outward: emergency rooms close, local pharmacies often shutter, and residents may travel hours to get a prescription filled.
For employers, that translates to a workforce facing longer delays for care, more missed workdays, and higher health-related costs.
The prescription access squeeze
Medicaid is the primary way many rural patients afford their medications.
When that coverage disappears, so does the ability to manage chronic conditions.
Patients may ration doses, switch to less effective therapies, or stop taking medication altogether.
The National Rural Health Association warns that disruptions to coverage will drive higher rates of untreated hypertension, diabetes, and other conditions that depend on steady medication adherence.
For employers, these gaps quickly become workforce issues.
Uncontrolled chronic conditions drive absenteeism, reduce productivity, and lead to higher-cost interventions that ultimately hit employer health plans.
HR leaders and benefits advisors serving rural populations will find themselves managing the fallout as workers struggle to stay healthy and remain on the job.
Physicians without visibility
Patients often talk about cost concerns with their doctors, expecting both the right treatment and an affordable one.
Yet without visibility into formulary rules, patient-specific copays, or available lower-cost alternatives, providers are constrained in how much they can help.
That lack of transparency leaves physicians in a difficult position, and employees return to the pharmacy counter facing bills they may not be able to pay.
This blind spot is often made worse by a maze of insurer portals, coupon apps and third-party discount platforms where the promise of "help" often turns into confusion.
A 2023 Harris Poll found that more than 70% of Americans feel the health care system is failing to meet their needs, citing affordability and fragmentation as leading sources of frustration.
Temporary funding vs. a long-term crisis
Lawmakers included a one-time lifeline in the OBBBA: the Rural Health Transformation Program, a $50 billion grant pool intended to stabilize rural health systems over the next five years.
It's a substantial sum, but only a fraction of what's being removed from Medicaid over the same period.
Once the grant funding runs out, the financial cliff returns, and it'll be steeper than before.
That puts pressure on states, health systems, and employers to stretch every Medicaid dollar while preserving access to care.
For the workforce, the question is straightforward: will employees still be able to afford the prescriptions that keep them healthy enough to work?
Smarter prescribing as a force multiplier
In rural communities, every prescription has consequences for both health and employment.
Missed medications don't just worsen individual conditions; they disrupt workplaces through higher absenteeism and long-term health costs that erode benefits budgets.
Cost-containment technology can ease that strain by quietly surfacing clinically appropriate, lower-cost alternatives such as generics, biosimilars, or deprescribing opportunities, all aligned with plan formularies.
These tools operate in the background, giving physicians visibility without disrupting their workflow, while HR and benefits teams avoid the burden of added platforms or complex integrations.
For employers, the result is healthier, more productive workers and more predictable pharmacy spending.
Protecting the lifeline
Medicaid cuts of this scale will test the resilience of rural health care.
Without new approaches, the strain on hospitals, pharmacies, and patients will deepen, and the consequences will flow directly into the workplace.
The Rural Health Transformation Program buys states a limited window of time.
Using that time to implement strategies that safeguard prescription access could determine whether rural employers retain a stable, healthy workforce or face rising costs and shrinking productivity.
For employees in these communities, the difference is stark: maintaining access to essential medications or going without.
Ryan Czado, PharmD, MBA, is the chief pharmacy officer at RazorMetrics.
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.